Annual EBIT
-$54.92 M
-$8.52 M-18.35%
December 31, 2023
Summary
- As of February 7, 2025, ATYR annual earnings before interest & taxes is -$54.92 million, with the most recent change of -$8.52 million (-18.35%) on December 31, 2023.
- During the last 3 years, ATYR annual EBIT has fallen by -$39.01 million (-245.16%).
- ATYR annual EBIT is now -245.16% below its all-time high of -$15.91 million, reached on December 1, 2020.
Performance
ATYR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$18.14 M
-$828.00 K-4.78%
September 1, 2024
Summary
- As of February 7, 2025, ATYR quarterly earnings before interest & taxes is -$18.14 million, with the most recent change of -$828.00 thousand (-4.78%) on September 1, 2024.
- Over the past year, ATYR quarterly EBIT has dropped by -$828.00 thousand (-4.78%).
- ATYR quarterly EBIT is now -1075.95% below its all-time high of $1.86 million, reached on March 1, 2020.
Performance
ATYR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$68.05 M
-$5.53 M-8.84%
September 1, 2024
Summary
- As of February 7, 2025, ATYR TTM earnings before interest & taxes is -$68.05 million, with the most recent change of -$5.53 million (-8.84%) on September 1, 2024.
- Over the past year, ATYR TTM EBIT has dropped by -$5.53 million (-8.84%).
- ATYR TTM EBIT is now -1047.61% below its all-time high of -$5.93 million, reached on March 1, 2014.
Performance
ATYR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ATYR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.4% | -4.8% | -8.8% |
| 3 y3 years | -245.2% | -128.2% | -46.6% |
| 5 y5 years | -67.3% | -128.2% | -46.6% |
ATYR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -61.5% | at low | -128.2% | at low | -100.1% | at low |
| 5 y | 5-year | -245.2% | at low | -1076.0% | at low | -346.5% | at low |
| alltime | all time | -245.2% | +5.2% | -1076.0% | at low | -1047.6% | at low |
ATyr Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$18.14 M(+4.8%) | -$68.05 M(+8.8%) |
| Jun 2024 | - | -$17.32 M(+4.1%) | -$62.52 M(+6.4%) |
| Mar 2024 | - | -$16.64 M(+4.2%) | -$58.77 M(+7.0%) |
| Dec 2023 | -$54.92 M(+18.3%) | -$15.96 M(+26.5%) | -$54.92 M(+17.1%) |
| Sep 2023 | - | -$12.62 M(-7.0%) | -$46.91 M(-1.8%) |
| Jun 2023 | - | -$13.56 M(+6.0%) | -$47.79 M(+2.1%) |
| Mar 2023 | - | -$12.79 M(+60.8%) | -$46.81 M(+0.9%) |
| Dec 2022 | -$46.40 M(+36.4%) | - | - |
| Dec 2022 | - | -$7.95 M(-41.1%) | -$46.40 M(-1.5%) |
| Sep 2022 | - | -$13.49 M(+7.2%) | -$47.09 M(+13.9%) |
| Jun 2022 | - | -$12.58 M(+1.7%) | -$41.33 M(+5.5%) |
| Mar 2022 | - | -$12.38 M(+43.3%) | -$39.19 M(+15.2%) |
| Dec 2021 | -$34.02 M(+113.8%) | -$8.64 M(+11.8%) | -$34.02 M(+12.2%) |
| Sep 2021 | - | -$7.73 M(-26.0%) | -$30.32 M(+4.2%) |
| Jun 2021 | - | -$10.45 M(+45.0%) | -$29.10 M(+16.5%) |
| Mar 2021 | - | -$7.20 M(+45.8%) | -$24.97 M(+56.9%) |
| Dec 2020 | -$15.91 M(-30.8%) | -$4.94 M(-24.1%) | -$15.91 M(-6.0%) |
| Sep 2020 | - | -$6.51 M(+3.1%) | -$16.93 M(+6.4%) |
| Jun 2020 | - | -$6.32 M(-439.9%) | -$15.92 M(+4.4%) |
| Mar 2020 | - | $1.86 M(-131.2%) | -$15.24 M(-33.7%) |
| Dec 2019 | -$22.98 M | -$5.96 M(+8.4%) | -$22.98 M(-0.0%) |
| Sep 2019 | - | -$5.50 M(-2.5%) | -$22.98 M(-4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$5.64 M(-4.0%) | -$24.16 M(-15.2%) |
| Mar 2019 | - | -$5.88 M(-1.4%) | -$28.48 M(-13.2%) |
| Dec 2018 | -$32.82 M(-30.4%) | -$5.96 M(-10.7%) | -$32.82 M(-13.8%) |
| Sep 2018 | - | -$6.68 M(-33.0%) | -$38.06 M(-9.8%) |
| Jun 2018 | - | -$9.96 M(-2.5%) | -$42.21 M(-4.4%) |
| Mar 2018 | - | -$10.22 M(-8.8%) | -$44.15 M(-6.3%) |
| Dec 2017 | -$47.15 M(-18.6%) | -$11.20 M(+3.4%) | -$47.15 M(-2.7%) |
| Sep 2017 | - | -$10.83 M(-9.1%) | -$48.47 M(-5.9%) |
| Jun 2017 | - | -$11.91 M(-9.9%) | -$51.51 M(-6.4%) |
| Mar 2017 | - | -$13.21 M(+5.5%) | -$55.04 M(-5.0%) |
| Dec 2016 | -$57.94 M(+21.7%) | -$12.53 M(-9.7%) | -$57.94 M(-6.4%) |
| Sep 2016 | - | -$13.87 M(-10.2%) | -$61.90 M(+4.3%) |
| Jun 2016 | - | -$15.43 M(-4.2%) | -$59.34 M(+8.3%) |
| Mar 2016 | - | -$16.11 M(-2.2%) | -$54.81 M(+15.1%) |
| Dec 2015 | -$47.62 M(+102.2%) | -$16.48 M(+45.7%) | -$47.62 M(+28.1%) |
| Sep 2015 | - | -$11.31 M(+3.8%) | -$37.16 M(+15.8%) |
| Jun 2015 | - | -$10.90 M(+22.1%) | -$32.08 M(+20.9%) |
| Mar 2015 | - | -$8.92 M(+48.0%) | -$26.55 M(+12.7%) |
| Dec 2014 | -$23.55 M(+20.5%) | -$6.03 M(-3.2%) | -$23.55 M(+34.4%) |
| Sep 2014 | - | -$6.23 M(+16.2%) | -$17.52 M(+55.2%) |
| Jun 2014 | - | -$5.36 M(-9.6%) | -$11.29 M(+90.4%) |
| Mar 2014 | - | -$5.93 M | -$5.93 M |
| Dec 2013 | -$19.54 M | - | - |
FAQ
- What is aTyr Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for aTyr Pharma?
- What is aTyr Pharma annual EBIT year-on-year change?
- What is aTyr Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for aTyr Pharma?
- What is aTyr Pharma quarterly EBIT year-on-year change?
- What is aTyr Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for aTyr Pharma?
- What is aTyr Pharma TTM EBIT year-on-year change?
What is aTyr Pharma annual earnings before interest & taxes?
The current annual EBIT of ATYR is -$54.92 M
What is the all time high annual EBIT for aTyr Pharma?
aTyr Pharma all-time high annual earnings before interest & taxes is -$15.91 M
What is aTyr Pharma annual EBIT year-on-year change?
Over the past year, ATYR annual earnings before interest & taxes has changed by -$8.52 M (-18.35%)
What is aTyr Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of ATYR is -$18.14 M
What is the all time high quarterly EBIT for aTyr Pharma?
aTyr Pharma all-time high quarterly earnings before interest & taxes is $1.86 M
What is aTyr Pharma quarterly EBIT year-on-year change?
Over the past year, ATYR quarterly earnings before interest & taxes has changed by -$828.00 K (-4.78%)
What is aTyr Pharma TTM earnings before interest & taxes?
The current TTM EBIT of ATYR is -$68.05 M
What is the all time high TTM EBIT for aTyr Pharma?
aTyr Pharma all-time high TTM earnings before interest & taxes is -$5.93 M
What is aTyr Pharma TTM EBIT year-on-year change?
Over the past year, ATYR TTM earnings before interest & taxes has changed by -$5.53 M (-8.84%)